Article info
Original articles
Hepatology
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
- Correspondence to Professor Frank Tacke, Department of Medicine III, University Hospital Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany; frank.tacke{at}gmx.net
Citation
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
Publication history
- Revised December 22, 2011
- Accepted December 23, 2011
- First published January 20, 2012.
Online issue publication
October 26, 2017
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions